[
    [
        {
            "time": "2020-01-01",
            "original_text": "二类苗高速增长，HPV疫苗供不应求，品种为王趋势下，管线即未来",
            "features": {
                "keywords": [
                    "二类苗",
                    "HPV疫苗",
                    "供不应求",
                    "品种为王",
                    "管线"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "二类苗高速增长，HPV疫苗供不应求，品种为王趋势下，管线即未来",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "康泰生物：公司研发项目冻干人用狂犬病疫苗采用的细胞是MRC-5株",
            "features": {
                "keywords": [
                    "康泰生物",
                    "冻干人用狂犬病疫苗",
                    "MRC-5株"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "康泰生物：公司研发项目冻干人用狂犬病疫苗采用的细胞是MRC-5株",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "康泰生物：冻干人用狂犬病疫苗的药品注册批件申请在准备中",
            "features": {
                "keywords": [
                    "康泰生物",
                    "冻干人用狂犬病疫苗",
                    "药品注册批件"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "康泰生物：冻干人用狂犬病疫苗的药品注册批件申请在准备中",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "康泰生物：公司核心产品四联苗新包装剂型已基本完成招标准入工作",
            "features": {
                "keywords": [
                    "康泰生物",
                    "四联苗",
                    "新包装剂型",
                    "招标准入"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "康泰生物：公司核心产品四联苗新包装剂型已基本完成招标准入工作",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-01",
            "original_text": "康泰生物：公司经营情况正常",
            "features": {
                "keywords": [
                    "康泰生物",
                    "经营情况正常"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：公司经营情况正常",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        }
    ]
]